期刊文献+

莫西沙星治疗COPD急性加重期的疗效观察 被引量:2

下载PDF
导出
作者 李彩英
出处 《现代中西医结合杂志》 CAS 2008年第15期2298-2299,共2页 Modern Journal of Integrated Traditional Chinese and Western Medicine
  • 相关文献

参考文献8

  • 1Stockey RA, O'Brien C, Pye A, et al. Relationship of sputum color to nature and outpatient management of acute exacerbations of COPD[J]. Chest,2000,117(6) : 1638 - 1645
  • 2姚婉贞 陈亚红.慢性阻塞性肺疾病急性加重的抗生素治疗策略.中国医学论坛报,2005,3(1):16-16.
  • 3刘又宁,陈民钧,赵铁梅,王辉,王睿,刘庆锋,蔡柏蔷,曹彬,孙铁英,胡云建,修清玉,周新,丁星,杨岚,卓建生,唐英春,张扣兴,梁德荣,吕晓菊,李胜歧,刘勇,俞云松,魏泽庆,应可净,赵峰,陈萍,侯晓娜.中国城市成人社区获得性肺炎665例病原学多中心调查[J].中华结核和呼吸杂志,2006,29(1):3-8. 被引量:787
  • 4谢灿茂,周宇麒.慢性阻塞性肺疾病急性加重的诊断与治疗新进展[J].中华结核和呼吸杂志,2005,28(5):346-348. 被引量:80
  • 5梁慧芬.MIMS呼吸系统疾病用药指南[M].2版.香港:美迪医迅亚太有限公司,2005:148-164
  • 6Anzueto A, Niederman MS, Pearle J, et al. Community-Acquired Pneumonia Recovery In the Elderly(CAPRIE) :Efficacy and safety of moxifloxacin versus that of levofloxacin therapy[J]. Clin Infect Dis,2006,42(1) :73 - 81
  • 7Wilson R,Jones P, Schaberg T. Antibiotic treatmment and factors influencing short and long term outcomes of acute exacerbations of chronic bronchitis[J ]. Thorax, 2006,61 : 337 - 342
  • 8Miravitlles M, Zalacain R, Murio C, et al. Speed of recovery from acute exacerbations of chronic obstructive pulmonary disease after treatment with antimicrobials. Result of a two-year study[J]. Clin Drug Invest,2003,23:439 - 450

二级参考文献40

  • 1Ngeow YF,Suwanjutha S,Chantarojanasriri T,et al.An asian study on the prevalence of atypical respiratory pathogens in community-acquired pneumonia.Int J Infect Dis,2005,9:144-153.
  • 2Lepow ML,Balassanian N,Emmerich J,et al.Interrelationships of viral,mycoplasmal,and bacterial agents in uncomplicated pneumonia.Am Rev Respir Dis,1968,97:533-545.
  • 3Lim WS,Macfarlane JT,Boswell TC,et al.Study of community acquired pneumonia aetiology(SCAPA) in adults admitted to hospital:implications for management guidelines.Thorax,2001,56:296-301.
  • 4Niederman MS,Mandell LA,Anzueto A,et al.Guidelines for the management of adults with community-acquired pneumonia.Diagnosis,assessment of severity,antimicrobial therapy,and prevention.Am J Respir Crit Care Med,2001,163:1730-1754.
  • 5Heffelfinger JD,Dowell SF,Jorgensen JH,et al.Management of community-acquired pneumonia in the era of pneumococcal resistance:a report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group.Arch Intern Med,2000,160:1399-1408.
  • 6Burge S, Wedzicha JA. COPD exacerbations: definitions and classifications. Eur Respir J Supp1,2003,41:46s-53s.
  • 7Seemunsal TA, Donaldson GC f Bhowmik A, et al. Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med,2000,161 : 1608-1613.
  • 8Buhl R, Farmer SG. Current and future pharmacologic therapy of exacerbations in chronic obstructive pulmonary disease and asthma.Proc Am Thorac Soc.2004.1:136-142.
  • 9Anthonisen NR, Manfreda J, Warren CP, et al. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med, 1987,106 : 196-204.
  • 10Rodriguez-Roisin R. Toward a consensus definition for COPD exacerbations. Chest,2000,117(5 Suppl 2) :398SM01S.

共引文献864

同被引文献6

  • 1慢性阻塞性肺疾病诊治指南(2007年修订版)[J].中华内科杂志,2007,46(3):254-261. 被引量:1794
  • 2中华人民共和国卫生部.2007年中国卫生统计年鉴[M].北京:中国协和医科大学出版社,2000.
  • 3Prim Care Respir J.2010 Nov 17.2010-07-0086-R2.10.4104.2010.00066.
  • 4Salpeter SR,Buckley NS,Salpet er EE.Met a analysis:anticholinergics,but not bet a agonists,reduce severe exacerbat ionsand respirat ory mortality in COPD[J].J G.Int ern Med,2006,21(10):1011-1019.
  • 5Shelley R. Salpeter MD,Nicholas S. Buckley,Edwin E. Salpeter PhD.Meta-analysis: Anticholinergics, but not β-agonists, reduce severe exacerbations and respiratory mortality in COPD[J].Journal of General Internal Medicine.2006(10)
  • 6吴康松,谢强敏.慢性阻塞性肺疾病治疗药物的现状与展望[J].世界临床药物,2003,24(2):76-80. 被引量:16

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部